Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7. (scientific article published on 2 December 2011)

scientific article published on 2 December 2011

Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7. is …

instance of (P31):

scholarly article

Q13442814

External links are

P6179	Dimensions Publication ID	1012215026
P356	DOI	10.1186/1744-8069-7-92
P932	PMC publication ID	3248882
P698	PubMed publication ID	22136189
P5875	ResearchGate publication ID	51848433

P50

author

Giuseppe Lauria

Catharina G Faber

Mark Estacion

Sulayman D Dib-Hajj

Stephen G Waxman

Ingemar S J Merkies

Janneke G. J. Hoeijmakers

Chongyang Han

Monique M. Gerrits

Jin-Sung Choi

author name string

Joost P H Drenth

P2860

cites work

Intraepidermal nerve fiber density and its application in sarcoidosis

Q49009772

Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Q73167917

Comparison of thermal threshold tests to assess small nerve fiber function: limits vs. levels

Q73295882

Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis

Q79339251

Transfection of rat or mouse neurons by biolistics or electroporation

Q84255216

Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells

Q24314768

A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons

Q24546007

SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes

Q28118877

Small-fiber neuropathy

Q28220711

Paroxysmal extreme pain disorder (previously familial rectal pain syndrome)

Q28239536

Neurobiology: a channel sets the gain on pain

Q28278802

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the [...]

Q28288249

International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels

Q28289125

Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study

Q28297340

Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons

Q28569751

The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology

Q33340463

A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome

Q33504524

Pain perception is altered by a nucleotide polymorphism in SCN9A

Q33739909

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

Q34153575

SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels

Q34426317

Inherited erythermalgia: limb pain from an S4 charge-neutral Na channelopathy

Q34567504

Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders

Q34585790

Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function

Q35138509

Small fibre neuropathies.

Q36254814

Thermal testing: normative data and repeatability for various test algorithms

Q36727236

Mitochondrial dynamics and peripheral neuropathy

Q36958205

Sodium channels in normal and pathological pain

Q37724336

Classification of peripheral neuropathy: the long and the short of it.

Q38169176

A sodium channel gene SCN9A polymorphism that increases nociceptor excitability

Q39759228

Probability of conduction deficit as related to fiber length in random-distribution models of peripheral neuropathies

Q40002807

Sodium-calcium exchanger and multiple sodium channel isoforms in intra-epidermal nerve terminals.

Q41186134

Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes

Q41813169

A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia.

Q42549337

Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel.

Q42686664

Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia

Q43061175

Etiology of small-fiber neuropathy

Q43243469

Can robots patch-clamp as well as humans? Characterization of a novel sodium channel mutation

Q44180217

NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders.

Q46301976

P304

page(s)

P577

publication date

2011-12-02

P1433

published in

Molecular Pain

Q15766244

P1476

title

Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7.

P478

volume

Reverse relations

cites work (P2860)

Q90263528	A Novel Gain-of-Function Nav1.9 Mutation in a Child With Episodic Pain
Q37256342	A gain-of-function mutation in Nav1.6 in a case of trigeminal neuralgia
Q64062398	A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy
Q37150552	Advanced Genetic Testing Comes to the Pain Clinic to Make a Diagnosis of Paroxysmal Extreme Pain Disorder
Q47578766	Associated conditions in small fiber neuropathy - a large cohort study and review of the literature
Q58582878	CRMP2 and voltage-gated ion channels: potential roles in neuropathic pain
Q37112626	CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking
Q36032974	Ca2+ toxicity due to reverse Na+/Ca2+ exchange contributes to degeneration of neurites of DRG neurons induced by a neuropathy-associated Nav1.7 mutation
Q39155847	Complex management of a patient with refractory primary erythromelalgia lacking a SCN9A mutation
Q100761872	Computational pipeline to probe NaV1.7 gain-of-function variants in neuropathic painful syndromes
Q36633107	Development of a Rapid Throughput Assay for Identification of hNav1.7 Antagonist Using Unique Efficacious Sodium Channel Agonist, Antillatoxin
Q89502829	Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy
Q37065681	Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain
Q89787503	Erythromelalgia
Q38998012	Exploring pain pathophysiology in patients
Q41901986	Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn
Q30366617	Functional Effects of Schizophrenia-Linked Genetic Variants on Intrinsic Single-Neuron Excitability: A Modeling Study.
Q48430447	Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy.
Q45771999	Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy
Q38026870	Genetic aspects of sodium channelopathy in small fiber neuropathy
Q28542818	Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain
Q51184405	Hyperexcitable C nociceptors in fibromyalgia.
Q28548202	Inhibition of Inactive States of Tetrodotoxin-Sensitive Sodium Channels Reduces Spontaneous Firing of C-Fiber Nociceptors and Produces Analgesia in Formalin and Complete Freund's Adjuvant Models of Pain
Q38795017	Ion Channel Genes and Epilepsy: Functional Alteration, Pathogenic Potential, and Mechanism of Epilepsy
Q34402820	Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels.
Q89208606	Mutation in Nav 1.7 causes high olfactory sensitivity
Q38239544	Mutational consequences of aberrant ion channels in neurological disorders
Q47161919	NaV channel variants in patients with painful and nonpainful peripheral neuropathy
Q36290427	Network topology of NaV1.7 mutations in sodium channel-related painful disorders.
Q44663616	Neuropathy-associated Nav1.7 variant I228M impairs integrity of dorsal root ganglion neuron axons.
Q36832246	Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia
Q38210568	Painful and painless channelopathies.
Q57715626	Painful micturition in a small child: an unusual clinical picture of paroxysmal extreme pain disorder
Q38253772	Painful neuropathies: the emerging role of sodium channelopathies
Q26784432	Primary erythromelalgia: a review
Q46775764	Selective sodium channel blockers in trigeminal neuralgia
Q46987387	Small-fiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons.
Q34277762	Small-fibre neuropathies--advances in diagnosis, pathophysiology and management
Q38260278	Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use.
Q37636758	Targeted next-generation sequencing reveals further genetic heterogeneity in axonal Charcot-Marie-Tooth neuropathy and a mutation in HSPB1.
Q38066723	The Na(V)1.7 sodium channel: from molecule to man.
Q38241746	The role of sodium channels in painful diabetic and idiopathic neuropathy.
Q38239812	Translational pain research: Lessons from genetics and genomics
Q36323856	Truncated HSPB1 causes axonal neuropathy and impairs tolerance to unfolded protein stress
Q90560458	Yield of peripheral sodium channels gene screening in pure small fibre neuropathy
Q53067627	[Pain and analgesia : Mutations of voltage-gated sodium channels].